STAT

‘I propose that we grow up a little bit’: Biohackers grapple with when to reject mainstream science — and when to embrace it

At a gathering off the Las Vegas Strip, biohackers grapple with when to reject mainstream science — and when to embrace it.

LAS VEGAS — Biohackers have gained notoriety with provocative stunts like injecting themselves with CRISPR, an untested gene therapy, and an experimental herpes treatment. At a gathering of some 150 biohackers here on Saturday, nobody injected themselves on stage — though a few did get magnets implanted under their skin during the conference’s happy hour.

To be sure, the conference featured plenty of the brash talk and rage-against-the-machine attitude that has characterized a community built around bucking the conventions of mainstream science. But for the first time, the gathering — now in its fourth year — featured a hall of scientific posters and vendor booths, those hallmarks of any scientific conference. And on stage, leaders in the movement debated whether to embrace practices like

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min readIntelligence (AI) & Semantics
STAT+: Q&A: Defining Responsible AI In Health Care, With CHAI CEO Brian Anderson
CHAI CEO Anderson wants to build public trust in AI and empower patients and providers to have more informed conversations.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Approval For Sarepta Drug, MSF Closing Access Campaign And More
After months of haggling, Vertex Pharmaceuticals and the National Health Service in England reached agreement over access to several cystic fibrosis treatments, capping an end to a controversial, long-running saga:
STAT2 min read
STAT+: Pharmalittle: We’re Reading About EMA Plans For GLP-1 Shortages, Walgreens Store Closings, And More
The European Medicines Agency and member countries announced several steps to address shortages of GLP-1 drugs.

Related Books & Audiobooks